Medtronic (BUE:MDT) FFO


BUE:MDT Medtronic PLC BUE:MDT
67 GF Score
Price ARS31,180.00
GF Value ARS38,260.76
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic FFO?

FFO (Funds from operations) only applies to REITs.

BUE:MDT
67GF Score
Medtronic PLC BUE:MDT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medtronic (BUE:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of ARS31,180.00 is trading 18.5% below its estimated GF Value™ of ARS38,260.76. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BUE:MDT:

  • FFO:
  • GF Value™: ARS38,260.76 vs. price of ARS31,180.00 (18.5% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BUE:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
67GF Score

Get the complete analysis for BUE:MDT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS31,180.00
Price
ARS38,260.76
GF Value